NCT06417892 2026-04-21
Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Recruiting
Clinical Trials
10 trialsNCT06893380 2025-09-15
GENTIS
CHA University
Recruiting
NCT04871321 2025-08-26
Biomarker Discovery in Patients With Advanced Biliary Tract Cancer
CHA University
Completed
NCT03393741 2024-06-25
Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy
University of Wisconsin, Madison
Terminated
NCT06378840 2024-04-23
the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer
RenJi Hospital
Recruiting
NCT05953909 2023-07-20
ERI-Based-01
Fujian Cancer Hospital
Unknown
NCT05609903 2022-11-08
Anastase
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Completed
NCT02799862 2021-10-06
NEPTUN
iOMEDICO AG
Completed
NCT02555813 2020-10-19
Treatment of Pancreatic Cancer With Abraxane
Celgene
Completed
NCT02555696 2017-02-23
Abraxane in Treatment of Metastatic Breast Cancer
Celgene
Completed